Hugh McMillan
Professor, Department of Pediatrics, University of Ottawa
Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario
Email HughDr. McMillan is a Pediatric Neurologist with specialization in Clinical Neurophysiology and Neuromuscular medicine at the Children’s Hospital of Eastern Ontario. He is a Professor in the Department of Pediatrics, Faculty of Medicine at the University of Ottawa. He holds a Clinical Research Chair (Level 2) at the University of Ottawa and is a Clinical Investigator at the CHEO Research Institute
He has been an author of over 125 publications in peer-review journals and was a co-editor of a Pediatric Electromyography textbook. He is also a leader in clinical and translational research in pediatric neurology & neuromuscular medicine.
Dr. McMillan completed a Neuromuscular and Neurophysiology Fellowship at Boston Children’s Hospital, Harvard University and the Lahey Clinic, Tufts University; a Pediatric Neurology Residency at the Children’s Hospital of Eastern Ontario, University of Ottawa and a Pediatric Residency at McMaster Children’s Hospital, McMaster University.
Read more about Hugh
Recent publications
Rutter, MM, Crane, JL, Babalola, F, Benjamin, RW, Lam, C, McAdam, L et al.. Managing growth and puberty concerns in individuals with Duchenne muscular dystrophy: Updated guidance and future directions. J Neuromuscul Dis. 2026. 22143602261486896 PMID:42857968
Sbrocchi, AM, Ahmet, A, Kinnett, K, Lautatzis, ME, McMillan, HJ, Apkon, S et al.. A structured approach to address variability in the global management of adrenal insufficiency in Duchenne muscular dystrophy: the 2025 PJ Nicholoff steroid protocol. Front Neurol. 2026.17 1926817 PMID:42787106
Weber, DR, Ahmet, A, Kinnett, K, Lautatzis, ME, McMillan, HJ, Apkon, S et al.. Adrenal insufficiency in individuals with Duchenne muscular dystrophy treated with glucocorticoids: Insights from the past, current challenges, and future directions. J Neuromuscul Dis. 2026. 22143602261485046 PMID:42770351
Orbach, R, Gil Garzon, MR, Büning, H, Bönnemann, C, Muntoni, F, 289th ENMC Workshop participants et al.. 289th ENMC international workshop: assessing and managing emerging AAV related toxicities after gene therapy for neuromuscular disorders, 26 - 28 September 2025, Hoofddorp, The Netherlands. Neuromuscul Disord. 2026.67 107371 PMID:42668237
Halloun, R, Jackowski, S, Scharke, M, Dang, UJ, Alshammri, F, Ma, J et al.. Total body and appendicular lean mass by dual-energy X-ray absorptiometry are highly associated with muscle function and bone mineral density in Becker muscular dystrophy. J Neuromuscul Dis. 2026. 22143602261476364 PMID:42663311
Sutton, ER, Beauvais, A, Yaworski, R, McMillan, HJ, Kothary, R. Maternal-Fetal Administration of Risdiplam Partially Rescues the SMNΔ7 Mouse Model of Spinal Muscular Atrophy. Ann Neurol. 2026.100 (3)584-599 PMID:42458739
Degan, C, Tobin, RA, de Vries, SI, Jiménez-Requena, A, Peco, A, Guglieri, M et al.. Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroids. Skelet Muscle. 2026.16 (1) PMID:42443978
Nasomyont, N, Appel, A, Apkon, S, Hoskin, J, Surampudi, PN, Truba, N et al.. Navigating sexual health, fertility, and adult wellness in individuals with Duchenne muscular dystrophy: Current standards of care and future directions. J Neuromuscul Dis. 2026. 22143602261454423 PMID:42439098
Mah, JK, Lochmüller, H, Ward, L, Selby, K, Gonorazky, H, Sbrocchi, AM et al.. Expanding Vamorolone Treatment Access for Canadians with Duchenne Muscular Dystrophy. Can J Neurol Sci. 2026. 1-4 PMID:42438401
Alazem, H, Friesen, AH, Dennison, T, Nizam, A, Larin, ML, Longmuir, PE et al.. Mobile robotic walker enables precision moderately intense exercise and environmental exploration in a child with cerebral palsy GMFCS IV: assessment of use, user experience and quantitative impact in a home and hospital based setting. Disabil Rehabil Assist Technol. 2026.21 (6)3317-3327 PMID:42423986
See more on PubMed